The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model

Cryotherapy has emerged as a primary treatment option for prostate cancer(CaP); however, incomplete ablation in the periphery of the cryogenic lesion can lead to recurrence. Accordingly, we investigated the use of a nontoxic adjunctive agent, Vitamin D(3), with cryotherapy to sensitize CaP to low te...

Descripción completa

Detalles Bibliográficos
Autores principales: Santucci, Kimberly L., Snyder, Kristi K., Baust, John. M., Van Buskirk, Robert G., Mouraviev, Vladimir, Polascik, Thomas J., Gage, Andrew A., Baust, John G.
Formato: Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094482/
https://www.ncbi.nlm.nih.gov/pubmed/21221127
http://dx.doi.org/10.1038/pcan.2010.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094482/
https://www.ncbi.nlm.nih.gov/pubmed/21221127
http://dx.doi.org/10.1038/pcan.2010.52

Ejemplares similares